Obesity Combo Drug Effective In Trial
Links shared publicly online about this topic.
- 373total visits
Obesity Combo Drug Effective In Trial
View full resource at medicalnewstoday.com
Tags: Diabetes, Obesity, Migraine, Headache, Vascular Headache, Drug
Most Recently Shared on April 12, 2011 at 2:34 am By:
Obesity Combo Drug Effective In Trial: Obese adults who took a combination of two drugs already approved to trea... http://bit.ly/h3dSlu
Also Shared By:
Tranylcypromine antidepressant shows promise as cancer treatment — medicalxpress.com — Readability
readability.com — “Tranylcypromine antidepressant shows promise as cancer treatment — medicalxpress.com — Readability” View full resource at readability.com
Most Recently Shared on March 12, 2012 at 4:33 pm By:
HealthFuturesDigest Health Organization
GenMed: An antidepressant expands the effectiveness of a drug for acute myeloid leukemia; combo is in phase II trials. http://t.co/mZyqP8Sl
Rapid bone loss as possible side effect of anti-obesity drug
sciencedaily.com — “An endocrine hormone used in clinical trials as an anti-obesity and anti-diabetes drug causes significant and rapid bone loss in mice, raising concerns about its safe use, researchers have shown.” View full resource at sciencedaily.com
Most Recently Shared on February 13, 2012 at 1:35 pm By:
Sara Stein MD Doctor, Psychiatrist, and Physician
A potential anti-#Obesity drug leads to massive bone loss in animal studies - scratch this one. http://t.co/7bnaQw4k
Orexigen Therapeutics Provides a Regulatory Update on Contrave NDA
drugs.com — “Contrave (bupropion SR/naltrexone SR) is a new drug combination in development for the treatment of obesity. Contrave information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on June 6, 2011 at 11:13 pm By:
Drugs and Devices OW OW Health
Orexigen Therapeutics Provides a Regulatory Update on Contrave NDA: SAN DIEGO, June 3, 2011 /PRNewswire/ -... http://bit.ly/lQT9wy #drug
Orexigen Puts Obesity Drug on Hold in U.S. | ThirdAge
thirdage.com — “Orexigen said it is putting its bid for U.S. approval for a new obesity drug on hold after the FDA asked for more clinical trials on the drug's side effects.” View full resource at thirdage.com
Most Recently Shared on June 4, 2011 at 9:24 pm By:
Orexigen Puts Obesity Drug on Hold in U.S. http://bit.ly/mra3DH
Drug Combo Shows Promise for Obesity Treatment | Weight Loss Drugs | LiveScience
livescience.com — “A combination of two drugs, along with diet and exercise, may be an effective treatment for obesity. Participants who took the drugs, phentermine and topiramate, achieved a greater weight loss than those who took a placebo.” View full resource at livescience.com
Most Recently Shared on April 12, 2011 at 1:18 pm By:
LiveScience Science Enthusiast
Drug Combo Shows Promise for Obesity Treatment http://bit.ly/hzjhjK
Drug combo may be key in weight loss - Health - Diet and nutrition - msnbc.com
msnbc.msn.com — “A combination of two drugs --" along with advice regarding healthy diet and exercise --" may be an effective treatment for obesity, a new study suggests.” View full resource at msnbc.msn.com
Most Recently Shared on April 11, 2011 at 6:25 pm By:
msnbc.com - Health Health News
Drug combo may be key in weight loss http://on.msnbc.com/hCtLHA
Obesity Combo Drug Effective In Trial | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
keyvive.com — “Obesity Combo Drug Effective In Trial | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com” View full resource at keyvive.com
Most Recently Shared on April 11, 2011 at 4:43 pm By:
Obesity Combo Drug Effective In Trial: Obese adults who took a combination of two drugs… http://goo.gl/fb/Tp8yj
Obesity Combo Drug Effective In Trial - LAP-BAND Surgery and LAP-BAND Discussion Forum
lapbandtalk.com — “Obese adults who took a combination of two drugs already approved to treat obesity, migraine and epilepsy achieved up to 10% weight loss in 12 month...” View full resource at lapbandtalk.com
Most Recently Shared on April 11, 2011 at 12:48 pm By:
Alex Brecher Support and ePatient
Lap Band Talk - Obesity Combo Drug Effective In Trial http://bit.ly/gMhE3Y
Patients Lose Weight With Rejected Combo Pill (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- A combination drug denied FDA approval for treating obesity led to significantly better weight loss compared with placebo, according to a large phase III clinical trial.” View full resource at qualitypointtech.net
Most Recently Shared on April 11, 2011 at 2:35 am By:
Patients Lose Weight With Rejected Combo Pill (CME/CE): (MedPage Today) -- A combination drug denied FDA approval ... http://bit.ly/feQg7W
Experimental drug achieves unprecedented weight loss, clinical trial finds
sciencedaily.com — “An investigational combination of drugs already approved to treat obesity, migraine and epilepsy produced up to a 10 percent weight loss in obese individuals participating in a one-year clinical trial, according to researchers.” View full resource at sciencedaily.com
Most Recently Shared on April 11, 2011 at 1:13 am By:
Sara Stein MD Doctor, Psychiatrist, and Physician
#Obesity Great data about Qnexa (topamax and phentermine combo) with good year end results of 18-22 lbs wt loss.... http://fb.me/YGSfS449
Medical News: Patients Lose Weight With Rejected Combo Pill - in Primary Care, Obesity from MedPage Today
medpagetoday.com — “A combination drug denied FDA approval for treating obesity led to significantly better weight loss compared with placebo, according to a large phase III clinical trial.” View full resource at medpagetoday.com
Most Recently Shared on April 11, 2011 at 12:42 am By:
Patients Lose Weight With Rejected Combo Pill (CME/CE): (MedPage Today) -- A combination drug… http://goo.gl/fb/9UbFy
FDA Issues Complete Response to New Drug Application for Contrave for the Management of Obesity
drugs.com — “Contrave (bupropion SR/naltrexone SR) is a new drug combination in development for the treatment of obesity. Contrave information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on February 9, 2011 at 12:13 am By:
Drugs and Devices OW OW Health
FDA Issues Complete Response to New Drug Application for Contrave for the Management of Obesity: SAN DIEGO... http://bit.ly/i8PT1E #drug
VIVUS Provides Regulatory Update on Qnexa NDA
drugs.com — “Qnexa (phentermine and topiramate) is a new drug in development for the treatment of obesity. Qnexa information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on February 2, 2011 at 2:02 am By:
Drugs and Devices OW OW Health
VIVUS Provides Regulatory Update on Qnexa NDA: MOUNTAIN VIEW, Calif., Jan. 21, 2011 /PRNewswire/ -- VIVUS,... http://bit.ly/i3xzzL #drug
Medical News: FDA Says No to Weight-Loss Combo Drug - in Primary Care, Obesity from MedPage Today
medpagetoday.com — “A pill combining bupropion and naltrexone for weight loss (Contrave) won't receive the FDA's approval until its manufacturer, Orexigen, conducts a new clinical trial evaluating its cardiovascular risk” View full resource at medpagetoday.com
Most Recently Shared on February 1, 2011 at 5:50 pm By:
FDA Says No to Weight-Loss Combo Drug http://bit.ly/hL8N7y
Advertisement
MNT Diabetes News
@mnt_diabetes
Obesity Combo Drug Effective In Trial http://mnt.to/3TrY #diabetes
1 year ago...